Ginkgo Bioworks DNA Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $212.37M-64.9% | $605.74M-38.8% | $989.58M-27.7% | $1.37B-14.0% | ||
| $93.9M+6.6% | $88.05M-61.8% | $230.33M-56.8% | $533.45M— | ||
| $471.84M-21.7% | $602.74M-39.8% | $1B-30.9% | $1.45B-15.8% | ||
| $167.37M-17.8% | $203.72M+8.3% | $188.19M-40.2% | $314.77M+116% | ||
| $56.92M-21.5% | $72.51M-12.4% | $82.74M-25.5% | $111.04M+413% | ||
| $15.07M-69.1% | $48.7M-38.0% | $78.57M-30.0% | $112.19M+9.9% | ||
| $1.12B-18.7% | $1.38B-17.3% | $1.67B-34.4% | $2.54B+22.6% | ||
| $18.95M-31.6% | $27.71M-37.7% | $44.49M-68.6% | $141.5M-12.0% | ||
| $95.97M-10.5% | $107.27M-34.5% | $163.86M-5.3% | $172.96M+28.3% | ||
| $5.69M-42.7% | $9.92M-66.9% | $29.97M-15.2% | $35.34M-93.0% | ||
| 15.8B+315,999,900% | 5K0.0% | 5K-97.4% | 190K+18.0% | ||
| -$6.15B-5.4% | -$5.84B-10.3% | -$5.29B-20.3% | -$4.4B-91.4% | ||
| $508.59M-29.0% | $716.06M-34.7% | $1.1B-36.8% | $1.74B+15.3% | ||
| $1.12B-18.7% | $1.38B-17.3% | $1.67B-34.4% | $2.54B+22.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ginkgo Bioworks's total assets?
- Ginkgo Bioworks (DNA) holds $1.0B in total assets, down 20.1% year over year.
- How much debt does Ginkgo Bioworks have?
- Ginkgo Bioworks carries $410.7M in total debt against $443.2M of shareholders' equity, a debt-to-equity ratio of 0.93.
- How much cash does Ginkgo Bioworks have?
- Ginkgo Bioworks holds $188.7M in cash and equivalents.
- Can Ginkgo Bioworks cover its short-term obligations?
- Its current ratio is 5.15 — current assets exceed current liabilities.
- Where does Ginkgo Bioworks's balance sheet data come from?
- Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
